Correction of previously distributed press release
In the interim report published by Recipharm on February 21, 2019, there are a few errors in the segment analysis and at country level over the geographical distribution in note 4. This is now corrected, and the correct version of the interim report can be found on the company’s website. Contact informationThomas Eldered, CEO, telephone: +46 8 602 52 10Tobias Hägglöv, CFO, ir@recipharm.com, +46 8 602 52 00 This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through